Precursor Control Regulations (SOR/2002-359)

9.1 If a rail car, reusable container, intermodal tank container or other container, having a capacity of 9,000 L or more, was used to provide or send red or white phosphorus and the rail car or container is returned to the person who produced the phosphorous with residual amounts that cannot be offloaded under normally accepted operating procedures in the chemical industry, the person returning the rail car or container in that state is exempt from the requirements of these Regulations in respect of that activity.

10. A person shall not transport a Class A precursor in transit through Canada or tranship a Class A precursor in Canada that is coming from one country and going to another or possess a Class A precursor for either of those purposes except in accordance with a permit issued under section 40.

10.1 Despite sections 6 to 10 and 47, with respect to a Class A precursor that is a preparation or mixture, a person may sell, provide, send, transport, deliver, import, export, transport in transit through Canada, tranship in Canada, destroy or possess for those purposes if

• (a) the preparation or mixture is the subject of an authorization certificate under section 49; and

• (b) no notice indicating that the certificate has been revoked or is under suspension appears on the following Health Canada Internet site:

  http://www.hc-sc.gc.ca/dhp-mps/substancontrol/index_e.html

• 11. (1) An individual entering or returning to Canada and having in their possession a Class A precursor that is a preparation or mixture may import the preparation or mixture if

  • (a) the preparation or mixture is intended to treat a medical condition of the individual or an accompanying person for whom the individual is responsible;

  • (b) in the case of a preparation or mixture containing ephedra, ephedrine or pseudoephedrine, the preparation or mixture is packaged and labelled as a consumer product and the total quantity imported of the precursor contained in the preparation or mixture does not exceed

    • (i) in the case of ephedra, 20 g,

    • (ii) in the case of ephedrine, 0.4 g, and

    • (iii) in the case of pseudoephedrine, 3 g; and

  • (c) in the case of a preparation or mixture containing ergometrine or ergotamine, the preparation or mixture is packaged in a container with a label showing that it was dispensed under prescription in a pharmacy or hospital or by a physician and the total quantity imported of the precursor contained in the preparation or mixture does not exceed the lesser of

    • (i) a single prescribed course of treatment, and

    • (ii) a 90-day supply, based on the normal daily dose for the precursor.

• (2) An individual leaving Canada and having in their possession a Class A precursor that is a preparation or mixture may export the preparation or mixture if the requirements of subsection (1) are met, with any modifications that the circumstances require.